Exercise, future anticancer therapy?
- Details
- Category: Development
Several studies have demonstrated the benefits of exercise to improve the quality of life of people with cancer. But Dr. Fred Saad, urologist-oncologist and researcher at the University of Montreal Hospital Research Centre (CRCHUM), goes further. He believes that physical exercise has a direct effect on cancer, as effective as drugs, for treating patients with prostate cancer, even in advanced stages of the disease.
Fasting-like diet reduces multiple sclerosis symptoms
- Details
- Category: Research
Evidence is mounting that a diet mimicking the effects of fasting has health benefits beyond weight loss, with a new USC-led study indicating that it may reduce symptoms of multiple sclerosis. Scientists discovered that the diet triggers a death-and-life process for cells that appears critical for the body's repair.
Vitamin A may help improve pancreatic cancer chemotherapy
- Details
- Category: Research
Around 8,800 people in the UK are diagnosed with pancreatic cancer each year. It is known as the UK's deadliest cancer, with a survival rate of just 3 per cent. Chemotherapy and radiotherapy alone are relatively unsuccessful in treating the disease, and while surgery to remove the tumour offers the best chance of survival, most patients are diagnosed when the cancer has already spread to other organs.
Zika conspiracy theories on social media putting vulnerable people at risk
- Details
- Category: Research
Conspiracy theories and pseudoscientific claims refuting the facts around Zika virus vaccines could be putting vulnerable people at risk, according to a new study published in Vaccine. By analyzing social media in real time, researchers were able to identify conversations about Zika virus vaccines and pinpoint the conspiracy theories being discussed.
Large-scale HIV vaccine trial to launch in South Africa
- Details
- Category: Research
An early-stage HIV vaccine clinical trial in South Africa has determined that an investigational vaccine regimen is safe and generates comparable immune responses to those reported in a landmark 2009 study showing that a vaccine can protect people from HIV infection.
Zika virus protein could be vaccine target
- Details
- Category: Research
A viral protein known as NS5 is a promising target for vaccines against Zika and related viruses, according to National Institutes of Health (NIH) scientists and colleagues at Mount Sinai's Icahn School of Medicine. Their study, published online May 19, 2016 in Cell Host & Microbe, suggests that altering or removing the NS5 protein from Zika virus would allow the human body's own immune defenses to attack the virus.
Fighting the Zika virus with the power of supercomputing
- Details
- Category: Development
Rutgers is taking a leading role in an IBM-sponsored World Community Grid project that will use supercomputing power to identify potential drug candidates to cure the Zika virus. The project, known as OpenZika, employs a global team of scientists who will perform "virtual" experiments in a search of treatments for the fast-spreading virus that the World Health Organization has declared a global public health emergency.
More Pharma News ...
- Cancer-fighting properties of horseradish revealed
- What foods can help fight the risk of chronic inflammation?
- Diabetes drug found no better than placebo at treating NAFLD
- New microbiome research tool offers potential to revolutionise drug development
- Bengt Sjöberg donates SEK 2 billion to cancer research
- Investigational malaria vaccine protects healthy US adults for more than one year
- Why are women less likely to be prescribed statins than men?